Kimberly Bergeron, M.D.
NPI 1043291370 · Allergy Physician · Brentwood, TN
Provider details
- NPI number
- 1043291370
- Entity type
- Individual
- Primary specialty
- Allergy PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 30497 (TN)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,330 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Professional Service for Preparation and Provision of 1 Or More Antigens95165 | 526 | $13 |
| Test for Allergy Using Allergenic Extract95004 | 362 | $3 |
| Test for Allergy Using Allergenic Extract Injected Into Skin95024 | 171 | $7 |
| Professional Service for Multiple Injections of Allergen95117 | 168 | $11 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 40 | $118 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 19 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Levocetirizine Dihydrochloride | 70 | 21 |
| Fluticasone Propionate | 68 | 16 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 55 | — |
| Montelukast Sodium | 39 | 12 |
| Ipratropium Bromide | 34 | 12 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 25 | 19 |
| Azelastine Hcl | 22 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$164 across 7 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-14
- Last updated
- 2019-02-21
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.